Tango Therapeutics (TNGX)
(Delayed Data from NSDQ)
$7.14 USD
+0.23 (3.33%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $7.14 0.00 (0.00%) 6:14 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Cash flow Statements
Fiscal Year End for Tango Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -101.74 | -108.18 | -58.24 | -0.12 | NA |
Depreciation/Amortization & Depletion | -0.98 | 1.61 | 0.90 | 0.00 | NA |
Net Change from Assets/Liabilities | -37.97 | -18.49 | -11.35 | -0.14 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 22.71 | 15.98 | 9.16 | -0.07 | NA |
Net Cash From Operating Activities | -117.98 | -109.08 | -59.53 | -0.33 | NA |
Property & Equipment | -1.53 | -7.69 | -1.84 | 0.00 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | 42.95 | 34.09 | -181.60 | 0.00 | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | -166.75 | NA |
Net Cash from Investing Activities | 41.43 | 26.40 | -183.43 | -166.75 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 81.96 | 1.62 | 31.05 | 166.78 | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | -0.13 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.45 | -0.01 | 326.28 | 1.74 | NA |
Net Cash from Financing Activities | 82.41 | 1.62 | 357.33 | 168.39 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | 5.85 | -81.07 | 114.36 | 1.31 | NA |
Cash at Beginning of Period | 63.96 | 145.02 | 30.66 | 0.00 | NA |
Cash at End of Period | 69.81 | 63.96 | 145.02 | 1.31 | NA |
Diluted Net EPS | -1.08 | -1.23 | -0.94 | -0.04 | NA |
Fiscal Year End for Tango Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -63.47 | -37.91 | -101.74 | -70.98 |
Depreciation/Amortization & Depletion | NA | -1.32 | -0.75 | -0.98 | 0.77 |
Net Change from Assets/Liabilities | NA | -12.82 | -6.83 | -37.97 | -37.22 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 16.14 | 7.63 | 22.71 | 16.91 |
Net Cash From Operating Activities | NA | -61.46 | -37.86 | -117.98 | -90.52 |
Property & Equipment | NA | -0.52 | -0.20 | -1.53 | -1.30 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 2.01 | -11.01 | 42.95 | 8.87 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 1.50 | -11.20 | 41.43 | 7.57 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 44.29 | 42.98 | 81.96 | 81.12 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.45 | -0.18 |
Net Cash from Financing Activities | NA | 44.29 | 42.98 | 82.41 | 80.94 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -15.68 | -6.08 | 5.85 | -2.00 |
Cash at Beginning of Period | NA | 69.81 | 69.81 | 63.96 | 63.96 |
Cash at End of Period | NA | 54.13 | 63.73 | 69.81 | 61.96 |
Diluted Net EPS | NA | -0.24 | -0.35 | -0.30 | -0.23 |